Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 5 of 5 results for midodrine

  1. Orthostatic hypotension due to autonomic dysfunction: midodrine (ESNM61)

    Summary of the evidence on midodrine for orthostatic hypotension due to autonomic dysfunction to inform local NHS planning and decision-making

    Evidence summary
    Published
    6 October 2015

  2. Parkinson's disease in adults (NG71)

    This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care.

    NICE guideline
    Published
    19 July 2017
    View recommendations

    Sections for NG71

  3. Orthostatic hypotension treatment:- For people with Parkinson's disease, what is the most effective pharmacological treatment for orthostatic hypotension?Particular interventions and comparisons of interest are:- midodrine compared with fludrocortisone (primary comparison)- pyridostigmine- ephedrine - pseudoephedrine.

    hypotension?Particular interventions and comparisons of interest are:- midodrine compared with fludrocortisone (primary comparison)-...

    Research recommendation
    Published
    15 October 2018

  4. Postural hypotension in adults: midodrine (ESUOM5)

    This evidence summary has been updated and replaced by NICE evidence summary: new medicines 61.

    Evidence summary
    Published
    5 February 2013

  5. Research recommendations

    hypotension?Particular interventions and comparisons of interest are:- midodrine compared with fludrocortisone (primary comparison)-...